Author: Selina McKee

Patients with epilepsy in the UK will from this week have access to a novel treatment after Eisai launched Zebinix, a follow-on drug from the current gold standard therapy carbamazepine.

Amgen Ltd has been dealt a blow by the National Institute for Health and Clinical Excellence which is leaning towards barring patients with a rare blood disorder from access to the firm’s Nplate on the National Health Service.

NHS Employers has put out a call to National Health Service trusts to avoid going down the redundancies road in a bid to save money as the pressure grows for mass efficiency savings to help counter the budget constraints ahead.

The government’s flagship policy of improving patient choice seems to be taking a lot longer to infiltrate National Health Service culture than originally envisioned, findings of a patient survey by think-tank The King’s Fund indicate.

Conservative party leader David Cameron has launched a petition on the government to protect the National Health Service from spending cuts as he unveiled his party’s plans for the future direction of the service.